Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
How to buy Merck stock | US$82.68
Own your own MRK shares in just a few minutes.
Fact checked
US$82.68
current price
current price
US$1.77
change
change
2.188%
change %
change %
How to buy stocks in Merck
- Compare share trading platforms.To buy shares in a US company from Canada you’ll need to find a trading platform that offers access to US stock markets. If you’re just starting out, look for a platform with low brokerage and foreign exchange fees. Narrow down some brokers with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Merck. Find the share by name or ticker symbol: MRK. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Merck reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of US$82.68, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Merck, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Merck. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Price details for Merck (MRK)
| Open | $81.37 | Previous close | $80.91 |
| High | $82.91 | Change | $1.77 |
| Low | $81.34 | Change % | 2.188% |
| Close | $82.68 | Timestamp | 1597262520 |
| Volume | N/A | GMT offset | 0 |
Merck stock price
Use our graph to track the performance of MRK stocks over time.Compare online trading platforms
This is not a recommendation, it represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Merck company summary
Information last updated 2020-08-04.
Merck (MRK) is a leading Pharmaceuticals business based in the USA. Merck (MRK) is listed on the NYSE and employs 71000 staff.
Profile
| Industry | Drug Manufacturers—General | Currency symbol | $ |
| Code | MRK | Country name | USA |
| Type | Common Stock | Country ISO | US |
| Name | Merck & Co., Inc | ISIN | US58933Y1055 |
| Exchange | NYSE | CUSIP | 589331107 |
| Currency code | USD | Sector | Healthcare |
| Currency name | US Dollar | Full-time employees | 71000 |
Detailed company information
Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; and FUJIFILM Corporation. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Disclaimer: This information provided is general in nature only and does not take into account your personal objectives, financial situation or needs. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore is not appropriate for all investors. Past performance is not an indication of future results. Seek professional advice and consider your own personal circumstances before making any decision based on this information.